PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.

PPoosstteedd:: 1111//2200//1122

ccaass

CANNON BUILDING STATE OF DELAWARE TELEPHONE: (302) 744-4500 861 SILVER LAKE BLVD., SUITE 203 DEPARTMENT OF STATE FAX: (302) 739-2711 DOVER, DELAWARE 19904-2467 WEBSITE: WWW.DPR.DELAWARE.GOV DIVISION OF PROFESSIONAL REGULATION

AGENDA (amended items are marked with an asterisk*)

1.0 Call to Order 2.0 Review and Approval of Minutes

2.1 Meeting Minutes – October 17, 2012 3.0 President’s Report 4.0 Unfinished Business 4.1 Complaint Status

13-03-11 – Forwarded to Office of Attorney General 13-08-11 – Assigned 13-09-11 – Forwarded to Office of Attorney General 13-12-11 – Forwarded to Office of Attorney General 13-13-11 – Assigned 13-14-11 – Closed 13-15-11 – Assigned 13-19-11 – Forwarded to Office of Attorney General 13-02-12 – Assigned 13-03-12 – Assigned 13-04-12 – Assigned 13-05-12 – Assigned 13-06-12 – Closed 13-07-12 – Assigned 13-08-12 – Assigned* 4.2 Prescription Monitoring Program (PMP) Update - Samantha Nettesheim 5.0 New Business

5.1 Pharmacist Licensure Approval Ratifications

5.1.1 Angela Morris 5.1.2 Kayla Wolfe

PUBLIC MEETING NOTICE: BOARD OF PHARMACY DATE AND TIME: Wednesday, November 21, 2012 9:30 a.m. PLACE: 861 Silver Lake Boulevard, Dover, Delaware Conference Room A, second floor of the Cannon Building

Board of Pharmacy Agenda – November 21, 2012 Page 2

5.1.3 Hanan Urick 5.1.4 Tiffany Dichiara 5.1.5 Trang Bui 5.1.6 Sora Kang 5.1.7 Benjamin Rodgers 5.1.8 Felicia Glenn* 5.1.9 Jennifer DiRenzo* 5.1.10 Frank Prempeh* 5.1.11 Jennifer Empfield* 5.1.12 Vladimir Berkovich* 5.1.13 Wahed Unnisa* 5.2 Facility Licensure Approval Ratifications

5.2.1 Non–Resident Pharmacies

5.2.1.1 Catamaran Home Delivery 5.2.1.2 Total Pain Solutions 5.2.1.3 Aids Healthcare Foundation dba Moms Pharmacy 5.2.1.4 Specialty Rx, Inc. 5.2.1.5 Affinity Biotech, Inc. 5.2.1.6 Restore Rx, Inc. 5.2.1.7 Baxter Healthcare Corp.* 5.2.1.8 Genoa Healthcare of New Jersey, LLC* 5.2.1.9 Dogwood Pharmacy, Inc.* 5.2.1.10 Infinity Compounding Solutions, LLC* 5.2.1.11 Home Infusion Solutions, LLC (NJ)* 5.2.1.12 Home Infusion Solutions, LLC (PA)* 5.2.1.13 Wells Pharmacy Network, LLC* 5.2.2 Wholesale Distributors

5.2.2.1 Hercon Pharmaceuticals, LLC 5.2.2.2 Camber Pharmaceuticals Inc. 5.2.2.3 Henry Schein, Inc. 5.2.2.4 AbbVie US, LLC 5.2.2.5 Alvogen, Inc. 5.2.2.6 Tri-anim Health Services, Inc. 5.2.2.7 Exel Inc. 5.2.2.8 UPS Supply Chain Solutions, Inc.* 5.2.3 Medical Gas Dispensers*

5.2.3.1 Airgas, Inc. (MD) 5.2.3.2 Airgas, Inc. (NJ)

5.3 Pharmacist-In-Charge Interview

5.3.1 Rebecca Marryott 5.4 Consultant Pharmacist Interview

5.4.1 David Rabin 5.5 Presentation on the “Well Experience” – Walgreens 5.6 Drug Shortage Discussion*

Board of Pharmacy Agenda – November 21, 2012 Page 3

6.0 Committee Reports

6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David Dryden 6.2 Continuing Education – Sandy Robinson and Joli Martini 6.3 Consumer Affairs – Matt Maher and Jay Galloway 6.4 Professional Liaison – Sandy Robinson and Joli Martini

6.5 Controlled Substance Liaison – Howard Simon, Jay Galloway and David Dryden 7.0 Committee Updates Regarding Proposed Regulations

7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Cheryl Peterson and David Dryden

7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebury and David Dryden 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy

Robinson and David Dryden 8.0 Board Correspondence 9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia

Kluger 10.0 Other Business before the Board (for discussion only) 11.0 Public Comments 12.0 Next Meeting – January 16, 2013 13.0 Adjournment Please Take Note: To assure consideration of an application at a meeting, the Board office must receive all of these items no later

than 4:30 p.m. ten full working days before the meeting date:

• Completed, signed and notarized application form,

• Fee payment, and

• All required documentation.

A final amended agenda will be published to reflect any items received after the original agenda is posted.

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum.

Pursuant to 29 Delaware Code, Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however,

such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the

body’s meeting.

MEMBERS: PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us

IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING. THANK YOU.